Antibodies to polypeptides homologous to VEGF and BMP1

Details Antibodies to polypeptides homologous to VEGF and BMP1 Antibodies to polypeptides homologous to VEGF and BMP1

2008-05-13

2008-05-13

Allen, Marianne P (Department: 1647)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

C530S388100, C530S388230, C530S389100, C530S389200, C530S387900, C530S387100, C530S387300, C424S133100, C424S139100, C424S141100, C424S158100

Reexamination Certificate

active

10178442

ABSTRACT:
The present invention involves the identification and preparation of vascular endothelial growth factor-E (VEGF-E). VEGF-E is a novel polypeptide related to vascular endothelial growth factor (VEGF) and bone morphogenetic protein 1. VEGF-E has homology to VEGF including conservation of the amino acids required for activity of VEGF. VEGF-E can be useful in wound repair, as well as in the generation and regeneration of tissue.

REFERENCES:
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4877864 (1989-10-01), Wang et al.
patent: 5013649 (1991-05-01), Wang et al.
patent: 5106748 (1992-04-01), Wozney et al.
patent: 5166058 (1992-11-01), Wang et al.
patent: 5332671 (1994-07-01), Ferrara et al.
patent: 5399677 (1995-03-01), Wolfman et al.
patent: 5453419 (1995-09-01), Murakami et al.
patent: 5543394 (1996-08-01), Wozney et al.
patent: 5620867 (1997-04-01), Kiefer et al.
patent: 5631142 (1997-05-01), Wang et al.
patent: 5637480 (1997-06-01), Celeste et al.
patent: 5641756 (1997-06-01), Robinson
patent: 5661007 (1997-08-01), Wozney et al.
patent: 5670338 (1997-09-01), Murakami et al.
patent: 6391311 (2002-05-01), Ferrara et al.
patent: 6455283 (2002-09-01), Ferrara et al.
patent: 6620784 (2003-09-01), Ferrara et al.
patent: 6887982 (2005-05-01), Gao et al.
patent: 2003/0027998 (2003-02-01), Holtzman et al.
patent: 2004/0138417 (2004-07-01), Fitzpatrick et al.
patent: 2004/0219640 (2004-11-01), Ferrara et al.
patent: 2004/0235740 (2004-11-01), Ferrara et al.
patent: 2007/0031929 (2007-02-01), Ferrara
patent: 471754 (1996-07-01), None
patent: 370989 (1996-09-01), None
patent: WO 88/00205 (1988-01-01), None
patent: WO 94/01548 (1994-01-01), None
patent: WO 96/30046 (1996-10-01), None
patent: WO 98/07832 (1998-02-01), None
patent: WO 98/45332 (1998-10-01), None
patent: WO 99/37671 (1999-07-01), None
patent: WO99/46281 (1999-09-01), None
patent: WO 99/47677 (1999-09-01), None
patent: WO 00/04183 (2000-01-01), None
patent: WO 00/24774 (2000-04-01), None
patent: WO 00/18212 (2000-06-01), None
patent: WO 00/32221 (2000-06-01), None
patent: WO 00/34474 (2000-06-01), None
patent: WO 00/37641 (2000-06-01), None
patent: WO 00/39284 (2000-07-01), None
patent: WO 00/53758 (2000-09-01), None
patent: WO 00/59940 (2000-10-01), None
patent: WO 00/66736 (2000-11-01), None
Einhorn, M.D. Lawrence H., “Charles F. Kettering Prize. Clinical trails in testicular cancer”Cancer71(10) :3182-3184 (May 15, 1993).
Lyttle, D. et al., “Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus”Journal of Virology68(1) :84-92 (Jan. 1994).
Presta, L. et al., “Humanization of anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders”Cancer Research57(20) :4593-4599 (Oct. 15, 1997).
Remadi, S. et al., “Metastasizing placental site trophoblastic tumor: immunohistochemical and DNA analysis. 2 case reports and a review of literature”Archives of Gynecology and Obstetrics259(2) :97-103 (1997).
Yoshida, S. et al., “Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis”Molecular&Cellular Biology17(7) :4015-4023 (Jul. 1997).
“EMBL Database Accession No. AA631149”.
Achen et al., “Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)”Proc. Natl. Acad. Sci. USA95(2):548-553 (Jan. 20, 1998).
Adamis et al., “Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia-Associated Iris Neovascularization in a Nonhuman Primate”Arch. Ophthalmology114(1):66-71 (1996).
Aiello et al., “Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders”New England J. of Medicine331(22):1480-1487 (1994).
Berkman et al., “Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms”J. Clin. Invest.91(1):153-159 (1993).
Borgstrom et al., “Complete inhibition of angiogenesis and growth of microtumors by anti-vascular endothelial growth factor neutralizing antibody: novel concepts of angiostatic therapy from intravital videomicroscopy”Cancer Research56(17):4032-4039 (1996).
Brown et al., “Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract”Cancer Research53(19):4727-4735 (1993).
Brown et al., “Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer”Human Pathology26(1):86-91 (1995).
Burgess and Maciag, “The Heparin-Binding (Fibroblast) Growth Factor Family of Proteins”Annu. Rev. Biochem.58:575-606 (1989).
Clapp et al., “The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis”Endocrinology133(3):1292-1299 (1993).
Connolly et al , “Human Vascular Permeability Factor”Journal of Biological Chemistry264(33):20017-20024 (1989).
Dvorak et al., “Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis”American Journal of Pathology146(5):1029-1039 (1995).
Ferrara and Davis-Smyth., “The Biology of Vascular Endothelial Growth Factor.”Endocrine Reviews.18(1):4-25 (1997).
Ferrara and Henzel, “Pituitary Follicular Cells Secrete a Novel Heparin-binding Growth Factor Specific for Vascular Endothelial Cells”Biochem.&Biophys. Res. Comm.161(2) 851-858 (1989).
Ferrara et al., “Molecular and biological properties of the vascular endothelial growth factor family of proteins”Endo. Rev.13:18-32 (1992).
Ferrara et al.. “The vascular endothelial growth factor family of polypeptides”J. Cell. Biochem.47:211-218 (1991).
Folkman and Shing, “Angiogenesis”Journal of Biological Chemistry267:10931-10934 (1992).
Folkman et al.. “Induction of angiogenesis during the transition from hyperplasia to neoplasia”Nature339(6219):58-61 (1989).
Good et al., “A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin”Proc. Natl. Acad. Sci. USA87(17):6624-6628 (1990).
Horak et al., “Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer”Lancet340(8828):1120-1124 (1992).
Houck et al., “The Vascular Endothelial Growth Factor Family: Identification of a Fourth Molecular Species and Characterization of Alternative Splicing of RNA.”Mol Endocrinol.5:1806-1814 (1991).
Ishikawa et al., “Identification of Angiogenic Activity and the Cloning and Expression of Platelet-Derived Endothelial Cell Growth Factor.”Nature.338:557-562 (1989).
Keck et al., “Vascular Permeability Factor, An Endothelial Cell Mitogen Related to PDGF”Science246:1309-1312 (1989).
Kim et al., “Inhibition of Vascular Endothelial Growth Factor-Induced Angiogenesis Suppresses Tumour Growth in vivo”Nature362:841-844 (1993).
Klagsbrun and D'Amore, “Regulators of angiogenesis”Ann. Rev. Physiol.53:217-239 (1991).
Leung et al., “Vascular Endothelial Growth Factor is a Secreted Angiogenic Mitogen”Science246:1306-1309 (1989).
Levine et al., “Bone morphogenetic protein promotes vascularization and osteoinduction in performed hydroxyapatite in the rabbit”Annals of Plastic Surgery39(2):158-168 (Aug. 1997).
Lopez et al., “Transdifferentiated retinal pigment epithelial cells are immunoreative for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes”Invest. Ophthalmol. Vis. Sci.37(5):855-868 (1996).
Macchiarini et

Affiliated with

Also associated with

Rating

Antibodies to polypeptides homologous to VEGF and BMP1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antibodies to polypeptides homologous to VEGF and BMP1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies to polypeptides homologous to VEGF and BMP1 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3910018